DERM
Income statement / Annual
Last year (2025), Journey Medical Corp's total revenue was $61.86 M,
an increase of 10.20% from the previous year.
In 2025, Journey Medical Corp's net income was -$11.43 M.
See Journey Medical Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$61.86 M |
$56.13 M |
$79.18 M |
$73.67 M |
$63.13 M |
$44.53 M |
$34.92 M |
$42.34 M |
$4.54 M |
$22.59 M |
| Cost of Revenue |
$25.18 M
|
$20.88 M
|
$26.66 M
|
$30.78 M
|
$32.08 M
|
$14.59 M
|
$10.53 M
|
$1.18 M
|
$0.00
|
$0.00
|
| Gross Profit |
$36.68 M
|
$35.26 M
|
$52.52 M
|
$42.89 M
|
$31.05 M
|
$29.94 M
|
$24.39 M
|
$41.16 M
|
$4.54 M
|
$22.59 M
|
| Gross Profit Ratio |
0.59
|
0.63
|
0.66
|
0.58
|
0.49
|
0.67
|
0.7
|
0.97
|
1
|
1
|
| Research and Development Expenses |
$480.00 K
|
$9.86 M
|
$7.54 M
|
$10.94 M
|
$16.56 M
|
$0.00
|
$0.00
|
$80.55 M
|
$104.41 M
|
$83.17 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$44.37 M
|
$40.20 M
|
$43.91 M
|
$59.47 M
|
$39.83 M
|
$0.00
|
$19.13 M
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
| Other Expenses |
$0.00
|
-$1.13 M
|
$3.14 M
|
$0.00
|
$9.54 M
|
$22.09 M
|
$0.00
|
$2.02 M
|
$128.56 M
|
$0.00
|
| Operating Expenses |
$44.85 M
|
$48.93 M
|
$54.59 M
|
$70.41 M
|
$65.93 M
|
$22.09 M
|
$19.13 M
|
$255.15 M
|
$304.87 M
|
$113.21 M
|
| Cost And Expenses |
$70.03 M
|
$69.81 M
|
$81.25 M
|
$101.19 M
|
$98.02 M
|
$36.68 M
|
$29.66 M
|
$256.32 M
|
$304.87 M
|
$113.21 M
|
| Interest Income |
$589.00 K
|
$757.00 K
|
$322.00 K
|
$60.00 K
|
$2.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$3.70 M
|
$2.70 M
|
$1.70 M
|
$2.02 M
|
$7.03 M
|
$698.00 K
|
$255.00 K
|
$15.64 M
|
$8.14 M
|
$1.54 M
|
| Depreciation & Amortization |
$4.35 M
|
$3.52 M
|
$3.86 M
|
$4.37 M
|
$2.56 M
|
$1.43 M
|
$1.21 M
|
$555.00 K
|
$339.00 K
|
$123.00 K
|
| EBITDA |
-$3.83 M |
-$8.40 M |
$1.92 M |
-$23.18 M |
-$32.77 M |
$9.28 M |
$6.44 M |
-$205.54 M |
-$294.78 M |
-$87.42 M |
| EBITDA Ratio |
-0.06
|
-0.15
|
0.02
|
-0.31
|
-0.52
|
0.21
|
0.18
|
-4.85
|
-64.92
|
-3.87
|
| Operating Income Ratio |
-0.13
|
-0.24
|
-0.03
|
-0.37
|
-0.55
|
0.18
|
0.15
|
-5.05
|
-66.14
|
-4.01
|
| Total Other Income/Expenses Net |
-$3.20 M
|
-$934.00 K
|
-$1.56 M
|
-$2.05 M
|
-$7.48 M
|
-$698.00 K
|
-$255.00 K
|
-$7.75 M
|
-$2.94 M
|
$1.54 M
|
| Income Before Tax |
-$11.37 M
|
-$14.61 M
|
-$3.63 M
|
-$29.57 M
|
-$42.36 M
|
$7.15 M
|
$5.00 M
|
-$221.73 M
|
-$303.26 M
|
-$89.08 M
|
| Income Before Tax Ratio |
-0.18
|
-0.26
|
-0.05
|
-0.4
|
-0.67
|
0.16
|
0.14
|
-5.24
|
-66.78
|
-3.94
|
| Income Tax Expense |
$60.00 K
|
$61.00 K
|
$221.00 K
|
$63.00 K
|
$1.63 M
|
$1.87 M
|
$1.38 M
|
-$194.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$11.43 M
|
-$14.67 M
|
-$3.85 M
|
-$29.63 M
|
-$43.99 M
|
$5.28 M
|
$3.63 M
|
-$221.54 M
|
-$303.26 M
|
-$89.08 M
|
| Net Income Ratio |
-0.18
|
-0.26
|
-0.05
|
-0.4
|
-0.7
|
0.12
|
0.1
|
-5.23
|
-66.78
|
-3.94
|
| EPS |
-0.47 |
-0.72 |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-1.76 |
| EPS Diluted |
-0.47 |
-0.72 |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-2.7 |
| Weighted Average Shares Out |
$24.50 M
|
$20.43 M
|
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$50.73 M
|
| Weighted Average Shares Out Diluted |
$24.50 M
|
$20.43 M
|
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$33.04 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
